Resultados de la búsqueda 21-30 of 12884 for Oxandrolone

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...